In order to better understand whether xCT (SLC7A11) can serve as a potential therapeutic target in patients with HNSCC, we analyzed a correlation between the level of xCT (SLC7A11) expression and the overall survival rate in patients with HNSCC using the TCGA data (Figure 1a). The gene discussed is SLC7A11; the disease is head and neck squamous cell carcinoma.